Citation | Comparators | Study Design | Findings1 |
---|---|---|---|
Gilmore & Milne 2001 | MPH, placebo | • Decision analytic model assessing cost-utility | Cost per each additional QALY gained with MPH treatment (versus no treatment) ranged from $15,509 to $19,281 when considering short-and medium-term benefits of MPH. Cost per QALY gained ranged from $9,850–$59,101 in sensitivity analyses |
Novartis data on file (2000; referenced in Lord & Paisley 2000) | MPH, placebo | • Decision analytic model assessing cost-utility | Cost per each additional QALY gained with MPH treatment (versus no treatment) was $27,766. |
Zupancic et al. 1998 | MPH, placebo | • Decision analytic model assessing cost-effectiveness | Cost per each additional point in the Conners Teacher Rating Scale gained with MPH treatment (versus no treatment) was $93, or $560 for a 6-point (1 SD) gain. |